When breast cancer spreads beyond the breast, it becomes much more dangerous. The lungs are one of the most common places where this cancer spreads.
Doctors have long known that lung metastasis is difficult to treat, but they have not fully understood why tumors grow so well in this environment. A new study from researchers at the University of Colorado Anschutz Cancer Center offers an important clue.
The study, published in Cancer Research Communications, shows that breast cancer cells can use the lung’s own repair system to help themselves grow. This discovery may open the door to new treatments that focus not only on the cancer cells but also on the environment around them.
The lungs have a natural ability to repair damage. When the tiny air sacs in the lungs are injured, the body quickly activates a healing response. Cells in the lungs work together to remove damaged tissue and rebuild healthy structures. This process is essential for breathing and overall health.
However, when cancer cells enter the lungs, they interfere with this process. Instead of allowing normal healing, they keep the repair system active for too long. This leads to ongoing inflammation, which creates a supportive environment for tumors.
The researchers found that certain lung cells, called alveolar type II cells, play a key role. These cells normally help repair lung tissue. But in the presence of cancer, they begin to release signals that help tumors grow. At the same time, cancer cells send signals back to these lung cells, strengthening this harmful cycle.
This two-way communication creates a situation where the lung is constantly trying to heal, but the result is continued tumor growth. This explains why cancer can spread and thrive in the lungs.
To find a possible solution, the researchers tested a drug called roflumilast. This drug is already used to treat a lung disease called chronic obstructive pulmonary disease. In their experiments, the drug slowed the growth of tumors in the lungs of mice. It worked by changing the lung environment, making it less favorable for cancer cells.
This approach is different from traditional cancer treatments, which aim to kill cancer cells directly. Instead, it focuses on stopping the support system that helps cancer grow. This could be a powerful new strategy, especially for metastatic cancer.
One advantage of this drug is that it is already approved for use in humans. This means it could be tested in cancer patients more quickly than a brand-new drug. Researchers are now planning to study how it works alongside other treatments and whether it can improve patient outcomes.
The study also highlights the serious challenge of metastatic breast cancer. Around one in three patients with advanced breast cancer develop tumors in the lungs. At this stage, treatment options are limited, and survival rates are lower.
Looking ahead, scientists are exploring ways to deliver similar drugs directly to the lungs using inhalers. This could make treatment more targeted and reduce side effects.
In summary, this research provides a new understanding of how cancer spreads and grows. It shows that the body’s natural healing process can sometimes be turned against us. By targeting this process, doctors may be able to slow down cancer and improve treatment.
From a critical point of view, the study offers a strong explanation of how lung metastasis works and presents a realistic treatment option. However, it is still early research, and results from animal studies do not always translate directly to humans. Clinical trials will be needed to confirm the benefits and safety of this approach.
Even so, the findings are promising and could lead to new ways to treat one of the most challenging forms of cancer.
If you care about breast cancer, please read studies about how eating patterns help ward off breast cancer, and soy and plant compounds may prevent breast cancer recurrence.
For more health information, please see recent studies about how your grocery list can help guard against caner, and a simple way to fight aging and cancer.
Source: University of Colorado Anschutz Cancer Center.
